Randomized Trial to Improve Primary Care Patient Management and Patient Outcomes Using a Drug–Drug Interaction Test: Confirmation of the DECART Simulated Patient Clinical Utility Trial Results
Drug–drug interactions (DDIs) are a serious problem in the healthcare system, leading to excess healthcare utilization and costs. We conducted a second prospective randomized, controlled trial to further establish the real-world clinical utility of a novel assay that objectively identifies potential...
| Published in: | Diagnostics |
|---|---|
| Main Authors: | John Peabody, Joshua Schrecker, Rebecca Heltsley, David Paculdo, Enrico de Belen, Diana Tamondong-Lachica, M. Czarina Acelajado, Othman Ouenes, Trina Kennedy, Elaine Jeter |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-07-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/11/7/1266 |
Similar Items
Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease
by: John W Peabody, et al.
Published: (2023-04-01)
by: John W Peabody, et al.
Published: (2023-04-01)
Impact of medication nonadherence and drug-drug interaction testing on the management of primary care patients with polypharmacy: a randomized controlled trial
by: Randy E. David, et al.
Published: (2024-11-01)
by: Randy E. David, et al.
Published: (2024-11-01)
Editorial: Medicinal drugs, the effect on memories and beyond
by: Mónica Moreira-Rodrigues, et al.
Published: (2024-08-01)
by: Mónica Moreira-Rodrigues, et al.
Published: (2024-08-01)
Synthetic and Herbal Drugs Registered in Clinical Trials on COVID-19: a Review on Recent Research
by: Maryam Mehrabi, et al.
Published: (2023-09-01)
by: Maryam Mehrabi, et al.
Published: (2023-09-01)
REPORTING OF ADVERSE DRUG REACTIONS BY PATIENTS IN BULGARIA
by: Hristo Zaykov, et al.
Published: (2025-04-01)
by: Hristo Zaykov, et al.
Published: (2025-04-01)
Herbal - Synthetic Drug Interactions
by: Kintoko Kintoko, et al.
Published: (2023-08-01)
by: Kintoko Kintoko, et al.
Published: (2023-08-01)
IMPORTANT HERB-DRUG INTERACTIONS
by: Javor Kac, et al.
Published: (2004-09-01)
by: Javor Kac, et al.
Published: (2004-09-01)
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma
by: Erlend Skaga, et al.
Published: (2019-06-01)
by: Erlend Skaga, et al.
Published: (2019-06-01)
Evaluation of Drug Use Patterns of Out Patient Attendees in a Tertiary Care Teaching Hospital in Dermatology and Venereology Department as a Tool to Promote Rational Prescribing
by: Nushrat Noor, et al.
Published: (2014-12-01)
by: Nushrat Noor, et al.
Published: (2014-12-01)
Discussion of the classification of pediatric drug clinical trials in children's hospitals in China
by: Yong Yang, et al.
Published: (2024-07-01)
by: Yong Yang, et al.
Published: (2024-07-01)
Dynamic Boolean modeling of molecular and cellular interactions in psoriasis predicts drug target candidates
by: Eirini Tsirvouli, et al.
Published: (2024-02-01)
by: Eirini Tsirvouli, et al.
Published: (2024-02-01)
Randomized Trial on the Clinical Utility of a Novel Biomarker Panel to Identify Treatable Determinants of Chronic Pain
by: John Peabody, et al.
Published: (2020-07-01)
by: John Peabody, et al.
Published: (2020-07-01)
Trends in Kampo Medicine Usage as Supportive Care During Anticancer Drug Treatment in Japanese Patients: A Nationwide Cohort Analysis from Fiscal Years 2015 to 2021
by: Hiroaki Ohta, et al.
Published: (2025-02-01)
by: Hiroaki Ohta, et al.
Published: (2025-02-01)
Pharmacogenomics : tailoring drug therapy to individual patients
by: Eskandar KIROLOS Kirolos
Published: (2024-07-01)
by: Eskandar KIROLOS Kirolos
Published: (2024-07-01)
Pathogenesis of drug resistant epilepsy
by: S. M. Malyshev, et al.
Published: (2019-04-01)
by: S. M. Malyshev, et al.
Published: (2019-04-01)
Drug and cosmetic safety training for cadres of family welfare program
by: Tristiana Erawati, et al.
Published: (2024-05-01)
by: Tristiana Erawati, et al.
Published: (2024-05-01)
Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)–Never Change a Running System?
by: Katja S. Just, et al.
Published: (2021-10-01)
by: Katja S. Just, et al.
Published: (2021-10-01)
Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs
by: James D. Noyes, et al.
Published: (2021-08-01)
by: James D. Noyes, et al.
Published: (2021-08-01)
Analysis of questions about use of drugs in breastfeeding to Norwegian drug information centres
by: Jan Anker Jahnsen, et al.
Published: (2018-01-01)
by: Jan Anker Jahnsen, et al.
Published: (2018-01-01)
Accurate prediction of drug-target interactions in Chinese and western medicine by the CWI-DTI model
by: Ying Li, et al.
Published: (2024-10-01)
by: Ying Li, et al.
Published: (2024-10-01)
A disentangled generative model for improved drug response prediction in patients via sample synthesis
by: Kunshi Li, et al.
Published: (2025-06-01)
by: Kunshi Li, et al.
Published: (2025-06-01)
The future of cancer therapy: exploring the potential of patient-derived organoids in drug development
by: Cigir Biray Avci, et al.
Published: (2024-05-01)
by: Cigir Biray Avci, et al.
Published: (2024-05-01)
Potential inappropriate medications and drug–drug interactions in adverse drug reactions in the elderly: a retrospective study in a pharmacovigilance database
by: Huaqiao Jiang, et al.
Published: (2025-04-01)
by: Huaqiao Jiang, et al.
Published: (2025-04-01)
Neuroenhancement as Instrumental Drug Use: Putting the Debate in a Different Frame
by: Stephan Schleim
Published: (2020-09-01)
by: Stephan Schleim
Published: (2020-09-01)
The Potential of a Stratified Approach to Drug Repurposing in Alzheimer’s Disease
by: Chloe Anderson, et al.
Published: (2023-12-01)
by: Chloe Anderson, et al.
Published: (2023-12-01)
The antidepressant effect of combined extracts of Hypericum perforatum and Echium amoenum supplementation in patients with depression symptoms: A randomized clinical trial
by: Akram Sadeghi, et al.
Published: (2023-07-01)
by: Akram Sadeghi, et al.
Published: (2023-07-01)
Thin Layer Chromatographic Method for Detection of Conventional Drug Adulterants in Herbal Products
by: Christopher Johnson Mwankuna, et al.
Published: (2022-12-01)
by: Christopher Johnson Mwankuna, et al.
Published: (2022-12-01)
Exploring Human Misuse and Abuse of Veterinary Drugs: A Descriptive Pharmacovigilance Analysis Utilising the Food and Drug Administration’s Adverse Events Reporting System (FAERS)
by: Josie Dunn, et al.
Published: (2024-10-01)
by: Josie Dunn, et al.
Published: (2024-10-01)
InterPAD is a database of drug-drug interaction between phytochemicals and anticancer drugs
by: Aili Zhang, et al.
Published: (2025-07-01)
by: Aili Zhang, et al.
Published: (2025-07-01)
Drug utilisation trends in a physical rehabilitation hospital
by: Ljubojević Gordana, et al.
Published: (2019-01-01)
by: Ljubojević Gordana, et al.
Published: (2019-01-01)
Plant-Derived Natural Products: A Source for Drug Discovery and Development
by: Noureddine Chaachouay, et al.
Published: (2024-02-01)
by: Noureddine Chaachouay, et al.
Published: (2024-02-01)
An Evaluation of Irrational Drug Consumption in Shiraz Households in 2019
by: Zahra Kavousi, et al.
Published: (2022-03-01)
by: Zahra Kavousi, et al.
Published: (2022-03-01)
Application of Chiral Piperidine Scaffolds in Drug Design
by: Qiu-Shi Chen, et al.
Published: (2023-03-01)
by: Qiu-Shi Chen, et al.
Published: (2023-03-01)
In vitro drug testing using patient-derived ovarian cancer organoids
by: Lin-Yu Chen, et al.
Published: (2024-10-01)
by: Lin-Yu Chen, et al.
Published: (2024-10-01)
ASSESSMENT OF ANXIETY DISORDERS AND USE OF DRUGS AMONG ACADEMICS OF MEDICINE AT A UNIVERSITY IN THE SOUTH OF MINAS GERAIS, BRAZIL
by: Carolina Kobbaz Ferraresso, et al.
Published: (2021-12-01)
by: Carolina Kobbaz Ferraresso, et al.
Published: (2021-12-01)
Pharmacogenomic network analysis of the gene-drug interaction landscape underlying drug disposition
by: Yitian Zhou, et al.
Published: (2020-01-01)
by: Yitian Zhou, et al.
Published: (2020-01-01)
An herbal drug combination identified by knowledge graph alleviates the clinical symptoms of plasma cell mastitis patients: A nonrandomized controlled trial
by: Caigang Liu, et al.
Published: (2023-03-01)
by: Caigang Liu, et al.
Published: (2023-03-01)
Editorial: Utilizing omics strategies to discover new drug targets for cancers
by: Shujun Zhang, et al.
Published: (2024-11-01)
by: Shujun Zhang, et al.
Published: (2024-11-01)
Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs
by: Yao Liu, et al.
Published: (2022-10-01)
by: Yao Liu, et al.
Published: (2022-10-01)
Gastrointestinal Cancer Patient Derived Organoids at the Frontier of Personalized Medicine and Drug Screening
by: Zhenjie Yang, et al.
Published: (2024-08-01)
by: Zhenjie Yang, et al.
Published: (2024-08-01)
Similar Items
-
Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease
by: John W Peabody, et al.
Published: (2023-04-01) -
Impact of medication nonadherence and drug-drug interaction testing on the management of primary care patients with polypharmacy: a randomized controlled trial
by: Randy E. David, et al.
Published: (2024-11-01) -
Editorial: Medicinal drugs, the effect on memories and beyond
by: Mónica Moreira-Rodrigues, et al.
Published: (2024-08-01) -
Synthetic and Herbal Drugs Registered in Clinical Trials on COVID-19: a Review on Recent Research
by: Maryam Mehrabi, et al.
Published: (2023-09-01) -
REPORTING OF ADVERSE DRUG REACTIONS BY PATIENTS IN BULGARIA
by: Hristo Zaykov, et al.
Published: (2025-04-01)
